References
- Kang SS, Wong PWK, Bidani A, Milanez S. Plasma protein-bound homocyst(e)ine in patients requiring chronic haemodialysis. Clin Sci 1983; 65: 335–6
- Wilcken DEL, Gupta VJ, Betts AK. Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism. Clin Sci 1981; 61: 743–9
- Soria C, Chadefaux B, Coude M, Gaillard O, Kamoun P. Concentrations of total homocysteine in plasma in chronic renal failure. Clin Ghem 1990; 36: 2137–8
- Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol 1993; 40: 230–4
- Mudd SH, Poole JR. Labile methyl balances for normal humans on various dietary regimens. Metabolism 1975; 24: 721–35
- Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992; 38: S20–7
- Krützén E, Bäck SE, Nilsson-Ehle I, Nilsson-Ehle P. Plasma clearance of a new contrast agent, iohexol: a method far the assessment of glomerular filtration rate. J Lab VClin Med 1984; 104: 955–61
- Nilsson-Ehle P, Grubb A. New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney Int 1994; 46: S17–19
- Andersson A, Isaksson A, Brattström L, Hultberg B. Determination of homocysteine and other thiols in human plasma by high-performance liquid chromatography and a thiol-specific postcolumn derivatization procedure. Clin Chem 1993; 39: 1590–7
- Hamfelt A. A simplified method for determination of pyridoxal phosphate in biological samples. Uppsala J Sci Med 1986; 91: 105–9
- Stipanuk MH. Metaboh of sulfur-containing amino acids. Ann Rev Biochem 1986; 6: 179–209
- Jacobsson L. A method for the calculation of renal clearance based on a single plasma sample. Clin Phys 1983; 3: 297–305
- Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J. Net uptake of plasma homocysteine by the rat kidneyin vivoAtherosclerosis, In press
- Foreman JW, Wald H, Blumberg G, Pepe LM, Segal S. Homocysteine uptake in isolated renal cortical tubules. Metabolism 1982; 31: 613–19
- Arnadottir M, Brattström L, Simonsen O, et al. The effect of high dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 1993; 40: 236–40
- Clarke R, Daly L, Robinson K, et al. Hyperhomucystcinemia: an independent risk factor for vascular disease. N End J Med 1991; 324: 1149–55
- Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc 1992; 268: 877–81
- Ueland PM, Refsum R, Brattström L. Plasma homocysteine and cardiovascular disease. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function, RB Francis, Jr. Marcel Dekker, New York 1992; 183–235
- Selhub J, Jaques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332: 286–91
- Raine AEG, Margreiter R, Brunner FP, et al. Report on management of renal failure in Europe, XXII. NcphroI Dial Transplant 1992; 7 Suppl 1991; 2: 7–35